tiprankstipranks
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
Holding BBIO?
Track your performance easily

BridgeBio Pharma (BBIO) Financial Statements

1,003 Followers

BridgeBio Pharma Financial Overview

BridgeBio Pharma's market cap is currently ―. The company's EPS TTM is $-2.412; its P/E ratio is -9.64; BridgeBio Pharma is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-1.11. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 2.73M$ 2.17M$ 211.12M$ 1.75M$ 4.09M
Gross Profit$ 2.13M$ 1.57M$ 210.52M$ 496.00K$ 3.49M
EBIT$ -155.67M$ -52.61M$ -12.69M$ -150.06M$ -159.18M
EBITDA$ -154.13M$ -51.03M$ -11.09M$ -148.47M$ -157.54M
Net Income Common Stockholders$ -162.04M$ -73.46M$ -35.22M$ -168.15M$ -177.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 266.32M$ 447.77M$ 519.69M$ 434.88M$ 543.26M
Total Assets$ 664.98M$ 794.38M$ 849.33M$ 546.38M$ 655.01M
Total Debt$ 446.65M$ 447.13M$ 447.56M$ 459.55M$ 455.67M
Net Debt$ 180.33M$ -642.00K$ -72.13M$ 24.67M$ -87.59M
Total Liabilities$ 1.88B$ 594.09M$ 1.89B$ 1.89B$ 1.85B
Stockholders Equity$ -1.23B$ -1.09B$ -1.05B$ -1.35B$ -1.21B
Cash Flow-
Free Cash Flow$ -182.30M$ 72.26M$ -221.03M$ -125.25M$ -145.66M
Operating Cash Flow$ -180.57M$ 74.70M$ -219.54M$ -124.82M$ -145.23M
Investing Cash Flow$ 38.23M$ 3.04M$ 22.75M$ -66.00K$ 37.68M
Financing Cash Flow$ 707.00K$ -5.73M$ 279.55M$ -4.52M$ 307.04M
Currency in USD

BridgeBio Pharma Earnings and Revenue History

BridgeBio Pharma Debt to Assets

BridgeBio Pharma Cash Flow

BridgeBio Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis